文献速递关节外科

参考定价降低全膝关节植入物成本

Reference Pricing Reduces Total Knee Implant Costs.
PubMed 文献 · J Arthroplasty · 2020-10-16

本研究回顾性分析本机构实施参考定价前后各12个月共7148例全膝关节置换术(TKA),比较植入物及组件平均价格、无骨水泥TKA使用率和供应商数量。结果显示总体植入物成本下降16.7%(P < .0001),各组件成本至少下降11%(P = .0003),无骨水泥膝关节使用率增加9%(P < .0001;比值比1.94,95%CI = 1.69-2.24),无供应商业务流失;作者认为参考定价策略可显著节省成本。

要点

  • 参考定价实施后总体植入物成本下降16.7%(P < .0001)。
  • 所有膝关节组件成本至少下降11%(P = .0003)。
  • 无骨水泥膝关节使用率增加9%(P < .0001;OR 1.94,95%CI 1.69-2.24)。

核心结论

  • 参考定价策略显著降低了本机构TKA植入物成本。
  • 植入物成本降低与外科医生手术量无关。
  • 参考定价后新技术使用更频繁。
  • 作者认为该策略为其他医院提供了显著的节省成本方法。

研究设计与样本

  • 回顾性分析本机构实施参考定价前12个月(2017年5月至2018年)与实施后最近12个月(2019年3月至2020年)的TKA数据。
  • 共纳入7148例TKA,其中实施前3790例,实施后3358例。
  • 比较总体植入物及组件平均价格、按医生手术量评估植入物成本、无骨水泥TKA使用率及采购公司数量。

主要发现

  • 总体植入物成本下降16.7%(P < .0001)。
  • 所有单个膝关节组件成本至少下降11%(P = .0003)。
  • 不同医生间价格无差异(P = .9758)。
  • 无骨水泥膝关节使用率增加9%(P < .0001;比值比1.94,95%置信区间1.69-2.24)。
  • 无供应商业务流失。

临床怎么用

  • 作者认为参考定价策略可为其他医院提供显著的节省成本方法。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Reference pricing establishes a set price a hospital is willing to pay for total knee arthroplasty (TKA) components regardless of vendor. The hospital contracts with vendors that sell implants to the hospital at the hospital-dictated prices. Orthopedic surgeons are free to utilize any implant system that has met the reference price using their best clinical judgment. Our hypothesis is that vendors will meet the set price and selection of different vendors and technologies will not change. METHODS: We retrospectively analyzed the 12 months prior (May 2017-2018) and the most recent 12 months after (March 2019-2020) implementing reference pricing at our institution. We investigated differences in average prices for total implant and component costs. We evaluated cost of implants with respect to surgeon volume, assessed the rate of cementless TKAs used, and number of companies purchased from before and after reference pricing. RESULTS: In total, 7148 TKAs were included in the study with 3790 arthroplasties before and 3358 after implementation of reference pricing. Overall implant costs decreased by 16.7% (P < .0001). All individual knee component costs decreased by at least 11% (P = .0003). No difference in prices were found among surgeons (P = .9758). Cementless knee use increased by 9% (P < .0001; odds ratio 1.94, 95% confidence interval = 1.69-2.24). No vendor business was lost. CONCLUSION: The strategy of reference pricing significantly reduced costs for TKA implants at our institution. The reduction in implant costs was regardless of surgeon volume. Newer technologies were utilized more often after reference pricing. This strategy represents a significant cost-savings approach for other hospitals.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Fang CJ, Shaker JM, Stoker GE, et al. Reference Pricing Reduces Total Knee Implant Costs. J Arthroplasty. 2020. PMID: 33189499. doi:10.1016/j.arth.2020.10.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。